| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $59,847,620 ) (Continued on the next page) |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R00HL144822 | Improving Outcomes in Pediatric Obstructive Sleep Apnea with Computational Fluid Dynamics | 000 | 5 | NIH | 12/22/2023 | $224,101 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F30AI157421 | Silencer Control of T cell Homeostasis | 000 | 3 | NIH | 11/7/2023 | $52,694 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | U01AI157620 | Randomized trial of viral specific T-cell infusion to prevent viral infection after hematopoietic stem cell transplant. | 000 | 4 | NIH | 4/11/2024 | $753,425 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F31HL168819 | GDF10 in Neonatal Heart Development | 000 | 1 | NIH | 1/19/2024 | $40,635 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK135478 | Organoid-guided Precision Hepatology for Steatohepatitis | 000 | 1 | NIH | 2/7/2024 | $515,224 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL164420 | Trajectories of Regional Cardiopulmonary Structure and Function in A Longitudinal Cohort of Extremely Preterm Infants | 000 | 2 | NIH | 2/28/2024 | $714,415 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21GM150093 | Establishment of a multi-center biobank of patient-specific induced pluripotent stem cells for pediatric sepsis research | 001 | 2 | NIH | 4/22/2024 | $194,137 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01AI177359 | The TNF Superfamily Control of Pathological Remodeling Associated with Severe Asthma | 000 | 2 | NIH | 4/23/2024 | $515,004 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01AI176519 | Blocking granzyme-mediated immune suppression to enhance HIV vaccine efficacy | 000 | 2 | NIH | 1/23/2024 | $749,709 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21DE032877 | Molecular Basis of SIX2-related Frontonasal Dysplasia | 000 | 2 | NIH | 1/25/2024 | $214,650 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21CA280723 | Target the Dusp1 in Jak2 dependent myeloproliferative neoplasm (MPN) for curative treatment | 000 | 2 | NIH | 4/3/2024 | $178,205 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01CA278834 | The role of DNAJB1-PKAc-?-catenin axis in fibrolamellar HCC | 000 | 2 | NIH | 3/11/2024 | $586,241 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K23DK135797 | Disrupted sleep architecture in adolescents with functional abdominal pain disorders | 000 | 2 | NIH | 1/19/2024 | $191,688 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL168790 | Mechanisms governing the differentiation and maintenance of atrial identity | 000 | 2 | NIH | 3/29/2024 | $541,351 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01CA278834 | The role of DNAJB1-PKAc-?-catenin axis in fibrolamellar HCC | 001 | 2 | NIH | 4/16/2024 | $32,568 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | U01DK134976 | Cincinnati Children's Clinical Center for Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes | 000 | 2 | NIH | 3/6/2024 | $719,621 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL166335 | Early detection of pulmonary complications of hematopoietic stem-cell transplantation in children using hyperpolarized xenon MRI | 000 | 2 | NIH | 1/10/2024 | $634,864 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01EY034565 | Optimizing methotrexate use for the management of chronic pediatric non-infectious uveitis | 000 | 2 | NIH | 2/14/2024 | $591,273 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R35HL166430 | Decoding innate immune signaling in normal and myelodysplastic hematopoiesis | 000 | 2 | NIH | 12/20/2023 | $991,859 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL166283 | Elucidating the FOXF1 gene regulatory network in human alveologenesis | 000 | 2 | NIH | 1/30/2024 | $594,317 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R34HL158586 | Pragmatic Research on Diuretic Management in Early BPD (PRIMED) Pilot | 000 | 2 | NIH | 1/9/2024 | $209,428 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK133145 | Diabetic Memory in Hematopoietic Stem Cells | 001 | 2 | NIH | 12/19/2023 | $405,373 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HD110321 | Screen Smart: Using Digital Health to Improve HIV Screening and Prevention for Adolescents in the Emergency Department | 001 | 2 | NIH | 4/5/2024 | $709,008 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K01DK135647 | Microbial regulation of intestinal tuft cell homeostasis | 000 | 2 | NIH | 12/18/2023 | $140,271 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R00HD104902 | Genomic and functional analyses of Polycomb group proteins in mouse preimplantation development | 001 | 4 | NIH | 12/29/2023 | $160,584 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21CA268945 | A Pilot Feasibility Trial of a Tailored Intervention to Improve Adherence in Adolescents and Young Adults with Cancer | 001 | 2 | NIH | 4/17/2024 | $9,695 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21CA268945 | A Pilot Feasibility Trial of a Tailored Intervention to Improve Adherence in Adolescents and Young Adults with Cancer | 000 | 2 | NIH | 11/3/2023 | $174,539 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL162595 | Thrombospondin1-regulated atrophy in the heart | 000 | 2 | NIH | 11/8/2023 | $547,141 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F30AI167482 | Single Cell Analysis of Alloreactive CD8+ T Cells in Kidney Transplant Rejection | 000 | 2 | NIH | 10/25/2023 | $40,635 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL167200 | Role of apoE in HDL-mediated enhanced survival of human regulatory T-cells | 000 | 2 | NIH | 12/28/2023 | $589,817 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K08GM148957 | Mechanisms of cardiomyocyte dysfunction in pediatric septic shock | 000 | 2 | NIH | 1/5/2024 | $192,024 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS132504 | Advancing CNS drug delivery via epigenetic modulation | 001 | 2 | NIH | 4/19/2024 | $39,798 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS132504 | Advancing CNS drug delivery via epigenetic modulation | 000 | 2 | NIH | 12/4/2023 | $511,676 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL166245 | Defining PRC2 complex epigenomic control in alveolar progenitor cells | 000 | 2 | NIH | 11/8/2023 | $523,395 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F31HL167596 | Mucosal Associated Invariant T cells in the Obese-asthma endotype | 000 | 2 | NIH | 12/19/2023 | $40,635 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL160765 | Dissecting the role of the cardiac fibroblast in hypertrophy. | 000 | 3 | NIH | 3/22/2024 | $548,099 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | U01AI181966 | Consortium of Food Allergy Research Clinical Research Center at Cincinnati Children's Hospital Medical Center (CoFAR-CRC:CCHMC) | 000 | 1 | NIH | 3/1/2024 | $380,000 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | U01AI181966 | Consortium of Food Allergy Research Clinical Research Center at Cincinnati Children's Hospital Medical Center (CoFAR-CRC:CCHMC) | 001 | 1 | NIH | 3/4/2024 | $0 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 001 | 2 | NIH | 3/7/2024 | -$1,778,058 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 001 | 2 | NIH | 3/7/2024 | $1,778,058 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 000 | 2 | NIH | 12/25/2023 | $1,778,058 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R35HL171346 | Transcriptional and epigenetic mechanisms of alveologenesis and re-alveologenesis | 000 | 1 | NIH | 3/15/2024 | $1,122,351 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F32CA290798 | The role of ERBB2 signaling in HPV-induced pathologies | 000 | 1 | NIH | 4/4/2024 | $71,766 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K23AI175525 | Improving Anaphylaxis Outcomes Through Personalized Care Strategies | 000 | 1 | NIH | 2/20/2024 | $192,252 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK135479 | Genetic and Small Molecule Regulation of Mechanisms of Crohn?s Disease Stricture Formation | 000 | 1 | NIH | 4/23/2024 | $664,569 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL167700 | Pathogenesis of Vascular Anomalies with GNAQ mutations | 000 | 1 | NIH | 3/28/2024 | $548,780 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL171046 | Initiators of thrombotic microangiopathy | 000 | 1 | NIH | 11/28/2023 | $706,638 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K08AI180350 | Maternal B cells enforce fetal tolerance | 000 | 1 | NIH | 11/28/2023 | $193,212 |
| 2024 | 2024 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R13HL173950 | The 11th Annual PTCTC Educational Meeting, The First 100 Days After Stem Cell Transplant | 000 | 1 | NIH | 3/29/2024 | $22,000 |
|